Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21557 | 357 | 27.6 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2598 | 3136 | RIBONUCLEOTIDE REDUCTASE//TRIMIDOX//DIDOX |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HYDROXYUREA | Author keyword | 17 | 12% | 36% | 130 |
2 | GENET HUMAN THER Y | Address | 7 | 53% | 3% | 9 |
3 | TARGET CELL AVAILABILITY | Author keyword | 2 | 67% | 1% | 2 |
4 | RIGHT | Address | 2 | 33% | 1% | 5 |
5 | BISTHIOSEMICARBAZONATE GOLDIII COMPLEXES | Author keyword | 1 | 100% | 1% | 2 |
6 | DERMATOMYOSITIS LIKE ERUPTION | Author keyword | 1 | 100% | 1% | 2 |
7 | MACROERYTHROCYTOSIS | Author keyword | 1 | 100% | 1% | 2 |
8 | VS411 | Author keyword | 1 | 100% | 1% | 2 |
9 | ACUTE ALVEOLITIS | Author keyword | 1 | 40% | 1% | 2 |
10 | HYDROXY UREA | Author keyword | 1 | 40% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYDROXYUREA | 17 | 12% | 36% | 130 | Search HYDROXYUREA | Search HYDROXYUREA |
2 | TARGET CELL AVAILABILITY | 2 | 67% | 1% | 2 | Search TARGET+CELL+AVAILABILITY | Search TARGET+CELL+AVAILABILITY |
3 | BISTHIOSEMICARBAZONATE GOLDIII COMPLEXES | 1 | 100% | 1% | 2 | Search BISTHIOSEMICARBAZONATE+GOLDIII+COMPLEXES | Search BISTHIOSEMICARBAZONATE+GOLDIII+COMPLEXES |
4 | DERMATOMYOSITIS LIKE ERUPTION | 1 | 100% | 1% | 2 | Search DERMATOMYOSITIS+LIKE+ERUPTION | Search DERMATOMYOSITIS+LIKE+ERUPTION |
5 | MACROERYTHROCYTOSIS | 1 | 100% | 1% | 2 | Search MACROERYTHROCYTOSIS | Search MACROERYTHROCYTOSIS |
6 | VS411 | 1 | 100% | 1% | 2 | Search VS411 | Search VS411 |
7 | ACUTE ALVEOLITIS | 1 | 40% | 1% | 2 | Search ACUTE+ALVEOLITIS | Search ACUTE+ALVEOLITIS |
8 | HYDROXY UREA | 1 | 40% | 1% | 2 | Search HYDROXY+UREA | Search HYDROXY+UREA |
9 | DRUG INDUCED FEVER | 1 | 33% | 1% | 2 | Search DRUG+INDUCED+FEVER | Search DRUG+INDUCED+FEVER |
10 | DIDOX | 1 | 23% | 1% | 3 | Search DIDOX | Search DIDOX |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SKIN CHANGES SECONDARY | 33 | 83% | 5% | 19 |
2 | PIGMENTED NAIL BANDS | 14 | 100% | 2% | 7 |
3 | ACUTE ALVEOLITIS | 11 | 78% | 2% | 7 |
4 | PSEUDO DERMATOMYOSITIS | 8 | 100% | 1% | 5 |
5 | TERM HYDROXYUREA THERAPY | 7 | 67% | 2% | 6 |
6 | MULTIPLE SKIN TUMORS | 6 | 80% | 1% | 4 |
7 | CONTINUOUS INFUSION HYDROXYUREA | 6 | 100% | 1% | 4 |
8 | DERMATOMYOSITIS LIKE ERUPTION | 5 | 54% | 2% | 7 |
9 | HYDROXAMATE COMPOUNDS | 4 | 67% | 1% | 4 |
10 | INTRAVENOUS HYDROXYUREA | 2 | 67% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Dermatomyositis induced by drug therapy: A review of case reports | 2008 | 17 | 14 | 57% |
Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature | 2006 | 8 | 19 | 74% |
Hydroxyurea: a key player in cancer chemotherapy | 2012 | 13 | 57 | 26% |
Use of hydroxyurea in psoriasis | 1999 | 27 | 12 | 67% |
Pharmacokinetics and pharmacodynamics of hydroxyurea | 1998 | 62 | 41 | 46% |
Hydroxyurea in the treatment of HIV infection - Clinical efficacy and safety concerns | 2003 | 24 | 58 | 34% |
Hydroxyurea: new insights on an old drug | 1999 | 34 | 39 | 44% |
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature | 2003 | 8 | 18 | 67% |
Virostatics: A new class of anti-HIV drugs | 2007 | 8 | 62 | 40% |
Hydroxyurea to inhibit human immunodeficiency virus-1 replication | 1999 | 14 | 16 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENET HUMAN THER Y | 7 | 53% | 2.5% | 9 |
2 | RIGHT | 2 | 33% | 1.4% | 5 |
3 | CANC DAKAR | 1 | 50% | 0.3% | 1 |
4 | CELLULAR BIOTECHNOL EMBRYOL | 1 | 50% | 0.3% | 1 |
5 | CLIN PROGRAM INFECT DIS | 1 | 50% | 0.3% | 1 |
6 | DERMATOPATHOL WA | 1 | 50% | 0.3% | 1 |
7 | MED EXPT MED BIOCHEM SCI | 1 | 50% | 0.3% | 1 |
8 | NCI FREDERICKNIH | 1 | 50% | 0.3% | 1 |
9 | PHARM UH1451 | 1 | 50% | 0.3% | 1 |
10 | PHARMACOL LARGO F VITO 1 | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176667 | FETAL HEMOGLOBIN//HEMOGLOBINOPATHY THALASSEMIA UNIT//HYDROXYUREA |
2 | 0.0000111542 | RIBONUCLEOTIDE REDUCTASE//P53R2//TRIMIDOX |
3 | 0.0000108468 | CRISNATOL//PHARMACODYNAMIC ANALYSIS//ARYLMETHYLAMINOPROPANEDIOL |
4 | 0.0000077702 | HIV LATENCY//HIV CURE//HIV 1 LATENCY |
5 | 0.0000063744 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
6 | 0.0000061933 | ZIDOVUDINE//AZT//DIDANOSINE |
7 | 0.0000058200 | N ACYLSULFONAMIDE//BENZOTRIAZOLE METHODOLOGY//HETEROCYCL CPDS |
8 | 0.0000057312 | SUBUNGUAL MELANOMA//ONYCHOMATRICOMA//ACRAL LENTIGINOUS MELANOMA |
9 | 0.0000055336 | HAND FOOT SYNDROME//RADIATION RECALL//HAND FOOT SKIN REACTION |
10 | 0.0000049970 | DNTP IMBALANCE//BLC 2//MICROBIAL TEST SYSTEMS |